Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders

Por Gideon Obasanmi, PhD, M. Andrew Nesbit, PhD, Diego Cobice, PhD, Logan Mackay, PhD, Stuart McGimpsey, MBBCh, BAO, Mark Wappett, MRes, Aaron N. Cranston, PhD, Tara C.B. Moore, PhD
Publicado em 2022-06-01